Advertisement WellDoc and AstraZeneca partner to develop asthma management solution - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

WellDoc and AstraZeneca partner to develop asthma management solution

WellDoc Communications, a healthcare company, has partnered with AstraZeneca Pharmaceuticals to educate patients about the importance of their medicine in asthma control.

As part of its patient support program AstraZeneca’s respiratory franchise will utilize WellDoc’s web- and mobile-based asthma solution, including virtual messenger, air quality and pollen count alerts as well as online patient support tools, allowing patients to manage their condition, consistent with the treatment plan of the patient’s physician, throughout their day and in real time.

WellDoc’s asthma application is said to include many features that benefit patients, including reminders, alerts, medication data capture and pollen and air quality data.

Ryan Sysko, CEO of WellDoc, said: “We’re pleased to announce our collaboration with AstraZeneca. Our partnership demonstrates WellDoc’s ability to expand beyond diabetes into other chronic conditions, but our focus remains the same -the improvement of healthcare outcomes and reduction of healthcare costs.”